$43.23−0.41 (−0.94%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Amdocs (DOX) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 9.4% in FY25, net margin 12.5%, and free cash flow (~$645.1M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Returns vs FCF (121%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼9.4%
4,532.9
FY21→FY25CAGR +1.4%/yr
Net income ($M)▲14.5%
564.7
FY21→FY25CAGR −4.8%/yr
Free cash flow ($M)▲4.2%
645.1
FY21→FY25CAGR −2.6%/yr
Diluted EPS▲18.8%
5.05
buyback-liftedCAGR −1.3%/yr
What the receipts whisper · what a headline number hides
Share count
−13.1%
124.9mn → 108.4mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$104.0M
steady at 2.3% of revenue (−1.5% YoY).
Returns vs FCF
121%
$779.8M returned vs $645.1M of FCF in FY25. The gap comes off the balance sheet (see net cash).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
12¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 34.5% → 38.0%. Net margin 12.5% is above the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | FY25 † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 4,532.9 | 4,532.9 | 5,005.0 | 4,887.6 | 4,576.7 | 4,288.6 | ▼9.4% | +1.4% |
Cost of revenue | 2,811.3 | 2,811.3 | 3,249.6 | 3,159.9 | 2,957.5 | 2,811.0 | ▼13.5% | +0.0% |
Gross profit | 1,721.6 | 1,721.6 | 1,755.4 | 1,727.6 | 1,619.2 | 1,477.7 | ▼1.9% | +3.9% |
Research & development | 340.8 | 340.8 | 360.8 | 374.9 | 354.7 | 312.9 | ▼5.5% | +2.2% |
Selling, general & admin | 506.1 | 506.1 | 572.8 | 570.7 | 528.6 | 487.3 | ▼11.7% | +1.0% |
Total operating expenses | 989.9 | 989.9 | 1,126.8 | 1,073.6 | 954.4 | 879.0 | ▼12.1% | +3.0% |
Operating incomefeeds ROC rank | 731.7 | 731.7 | 628.6 | 654.0 | 664.8 | 598.7 | ▲16.4% | +5.1% |
Other income, net | −38.4 | −38.4 | −37.5 | −17.6 | −16.4 | 215.6 | — | — |
Pretax income | 693.2 | 693.2 | 591.1 | 636.4 | 648.4 | 814.3 | ▲17.3% | −3.9% |
Income tax | 125.5 | 125.5 | 94.8 | 93.4 | 98.9 | 125.9 | ▲32.4% | −0.1% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 564.7 | 564.7 | 493.2 | 540.7 | 549.5 | 688.4 | ▲14.5% | −4.8% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 5.05 | 5.05 | 4.25 | 4.49 | 4.44 | 5.32 | ▲18.8% | −1.3% |
Diluted shares (mn) | 108.45 | 108.45 | 112.89 | 117.35 | 120.84 | 124.87 | ▼3.9% | −3.5% |
| Margins | ||||||||
Gross margin22nd pct in Technology | 38.0% | 38.0% | 35.1% | 35.3% | 35.4% | 34.5% | ▲2.9pp | +3.5pp |
Operating margin | 16.1% | 16.1% | 12.6% | 13.4% | 14.5% | 14.0% | ▲3.6pp | +2.2pp |
Net margin59th pct in Technology | 12.5% | 12.5% | 9.9% | 11.1% | 12.0% | 16.1% | ▲2.6pp | −3.6pp |
† FY25 = fiscal 2025, through 2025-09-30; the trailing year is not available.
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2025-12-15 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Amdocs' revenue last fiscal year?
Amdocs reported revenue of $4,532.9M in fiscal 2025, down 9.4% from fiscal 2024.
What was Amdocs' net income?
Amdocs reported net income of $564.7M in fiscal 2025, a net margin of 12.5%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

